| 28th May 2020 7:00 am |
RNS |
Investor presentations |
| 26th May 2020 7:00 am |
RNS |
Appointment of Chairman |
| 22nd May 2020 4:15 pm |
RNS |
2019 Annual Report and 2020 AGM Notice |
| 21st May 2020 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 21st May 2020 4:35 pm |
RNS |
Price Monitoring Extension |
| 21st May 2020 7:00 am |
RNS |
Preliminary Results |
| 19th May 2020 7:00 am |
RNS |
Notice of Results |
| 11th May 2020 1:15 pm |
EQS |
Hardman & Co Research: Shield Therapeutics (STX): Reassuring trading update |
| 1st May 2020 7:00 am |
RNS |
Business and trading update |
| 30th Apr 2020 5:23 pm |
RNS |
Total Voting Rights Update |
| 27th Apr 2020 7:00 am |
RNS |
Further re. Directorate Change |
| 22nd Apr 2020 7:00 am |
RNS |
Directorate Change |
| 26th Mar 2020 4:42 pm |
RNS |
Second Price Monitoring Extn |
| 26th Mar 2020 4:36 pm |
RNS |
Price Monitoring Extension |
| 20th Mar 2020 11:36 am |
RNS |
Holding(s) in Company |
| 17th Mar 2020 2:06 pm |
RNS |
Second Price Monitoring Extn |
| 17th Mar 2020 2:00 pm |
RNS |
Price Monitoring Extension |
| 17th Mar 2020 7:00 am |
RNS |
AEGIS-H2H study update |
| 6th Mar 2020 7:00 am |
RNS |
Investor Presentation |
| 2nd Mar 2020 4:41 pm |
RNS |
Block Listing Application |
| 21st Feb 2020 11:14 am |
RNS |
Holding(s) in Company |
| 28th Jan 2020 12:15 pm |
EQS |
Hardman & Co Research: Shield Therapeutics (STX): Good demand for Feraccru in Europe |
| 27th Jan 2020 7:00 am |
RNS |
Business and trading update |
| 24th Jan 2020 7:00 am |
RNS |
Investor presentations |
| 14th Jan 2020 7:15 am |
EQS |
Hardman & Co Research: Shield Therapeutics (STX): Taking on China |
| 8th Jan 2020 7:00 am |
RNS |
China licence agreement for Feraccru/Accrufer |
| 12th Dec 2019 5:30 pm |
RNS |
Eland Oil & Gas |
| 29th Nov 2019 3:31 pm |
RNS |
Holding(s) in Company |
| 25th Nov 2019 7:00 am |
RNS |
QCA Corporate Governance Code |
| 30th Oct 2019 7:30 am |
EQS |
Hardman & Co Research: Shield Therapeutics (STX): More choice for clinicians and patients |
| 22nd Oct 2019 7:00 am |
RNS |
Positive results presented at UEG Week 2019 |
| 26th Sep 2019 7:00 am |
RNS |
Investor Presentation |
| 2nd Sep 2019 9:14 am |
EQS |
Hardman & Co Research: Shield Therapeutics (STX): FDA approval ushers in a new era for Shield |
| 29th Aug 2019 7:00 am |
RNS |
Investor presentations |
| 15th Aug 2019 10:17 am |
RNS |
Director/PDMR Shareholding |
| 7th Aug 2019 7:00 am |
RNS |
Half-year Report |
| 5th Aug 2019 11:22 am |
EQS |
Hardman & Co Research: Shield Therapeutics (STX) FDA approval opens door to major US opportunity |
| 31st Jul 2019 1:21 pm |
RNS |
Notice of Results |
| 26th Jul 2019 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 26th Jul 2019 2:00 pm |
RNS |
Price Monitoring Extension |
